Stocks
Monopar Therapeutics Inc.MNPR
NASDAQHealthcareBiotechnology$72.58
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing therapies for rare diseases and oncology, with a focus on advancing its lead candidate for a form of muscular dystrophy. Investors track it for its pipeline milestones and potential regulatory catalysts.
52W Range: $50.07-$124.82
Congressional Interest in Monopar Therapeutics Inc. (MNPR)
No congressional trades have been disclosed for Monopar Therapeutics Inc. (MNPR) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading MNPR?
No congressional trades found for this stock.